COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,168 Articles (22,703 medRxiv, 8,465 bioRxiv)

Most recent first Previous |  Page 1741: Articles 17401-17410  | Next

SARS-CoV-2 viability in time on experimental surfaces
Nikiforova, M., Siniavin, A., Shidlovskaya, E., Kuznetsova, N., Gushchin, V.
10.1101/2021.03.04.433846 — Posted: 2021-03-04
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
Ndeupen, S., Qin, Z., Jacobsen, S., Gibb, M., Estanbouli, H., Bouteau, A., Cardenas, J., Uthra, B., Wang, Y., Gu, J., Igyarto, B. Z.
10.1101/2021.03.04.430128 — Posted: 2021-03-04 Discussion: Onsite
SARS-CoV-2 variant with higher affinity to ACE2 shows reduced sera neutralization susceptibility
Vogel, M., Chang, X., Sousa Augusto, G., Mohsen, M. O., Speiser, D. E., Bachmann, M. F.
10.1101/2021.03.04.433887 — Posted: 2021-03-04
Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain
Kobiyama, K., Imai, M., Jounai, N., Nakayama, M., Hioki, K., Iwatsuki-Horimoto, K., Yamayoshi, S., Tsuchida, J., Niwa, T., Suzuki, T., Ito, M., Yamada, S., Watanabe, T., Kiso, M., Negishi, H., Temizoz, B., Ishigaki, H., Kitagawa, Y., Nguyen, C. T., Itoh, Y., Takeshita, F., Kawaoka, Y., Ishii, K. J.
10.1101/2021.03.04.433852 — Posted: 2021-03-04
Comparing SARS-CoV-2 case rates between pupils, teachers and the general population: results from Ger-many
Koestner, C., Letzel, S., Eggert, V., Beutel, T., Dietz, P.
10.1101/2021.03.04.21252877 — Posted: 2021-03-04
Saliva testing is accurate for early-stage and presymptomatic COVID-19
Johnson, A. J., Zhou, S., Hoops, S. L., Hillmann, B., Schomaker, M., Kincaid, R., Daniel, J., Beckman, K., Yohe, S., Nelson, A. C.
10.1101/2021.03.03.21252830 — Posted: 2021-03-04
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters
Dalvie, N. C., Rodriguez-Aponte, S. A., Hartwell, B. L., Tostanoski, L. H., Biedermann, A. M., Crowell, L. E., Kaur, K., Kumru, O., Carter, L., Yu, J., Chang, A., McMahan, K., Courant, T., Lebas, C., Lemnios, A. A., Rodrigues, K. A., Silva, M., Johnston, R. S., Naranjo, C. A., Tracey, M. K., Brady, J. R., Whittaker, C. A., Yun, D., Kar, S., Porto, M., Lok, M., Andersen, H., Lewis, M. G., Love, K. R., Camp, D. L., Silverman, J. M., Kleanthous, H., Joshi, S. B., Volkin, D. B., Dubois, P. M., Collin, N., King, N. P., Barouch, D. H., Irvine, D. J., Love, J. C.
10.1101/2021.03.03.433558 — Posted: 2021-03-04
Ribosome-profiling reveals restricted post transcriptional ex-pression of antiviral cytokines and transcription factors during SARS-CoV-2 infection
Alexander, M. R., Brice, A. M., Jansen Van Vuren, P., Rootes, C., Tribolet, L., Cowled, C., Bean, A. G. D., Stewart, C. R.
10.1101/2021.03.03.433675 — Posted: 2021-03-04
Ethnicity and COVID-19 outcomes among healthcare workers in the United Kingdom: UK-REACH ethico-legal research, qualitative research on healthcare workers' experiences, and stakeholder engagement protocol
Gogoi, M., Reed-Berendt, R., Al-Oraibi, A., Hassan, O., Wobi, F., Gupta, A., Abubakar, I., Dove, E., Nellums, L., Pareek, M.
10.1101/2021.03.03.21252737 — Posted: 2021-03-03
Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults
Costa, R., Bueno, F., Albert, E., Torres, I., Carbonell-Sahuquillo, S., Barres-Fernandez, A., Sanchez, D., Padron, C., Colomina, J., Lazaro-Carreno, M. I., Breton-Martinez, J. R., Martinez-Costa, C., Navarro, D.
10.1101/2021.03.03.21252814 — Posted: 2021-03-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).